Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry... Show more
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
BCHMY broke above its upper Bollinger Band on September 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on September 18, 2025. You may want to consider a long position or call options on BCHMY as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BCHMY just turned positive on September 22, 2025. Looking at past instances where BCHMY's MACD turned positive, the stock continued to rise in of 15 cases over the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.600) is normal, around the industry mean (5.194). P/E Ratio (36.481) is within average values for comparable stocks, (38.776). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.306). Dividend Yield (0.013) settles around the average of (0.038) among similar stocks. P/S Ratio (7.220) is also within normal values, averaging (10.091).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BCHMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCHMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
Industry ChemicalsMajorDiversified
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDZ | 4.14 | 0.07 | +1.72% |
Direxion Daily MSCI Em Mkts Bear 3X ETF | |||
KURE | 20.68 | 0.09 | +0.44% |
KraneShares MSCI All China Hlth Care ETF | |||
IBDS | 24.30 | -0.02 | -0.08% |
iShares iBonds Dec 2027 Term Corp ETF | |||
DDLS | 41.50 | -0.05 | -0.13% |
WisdomTree Dynamic Intl SmCap Eq ETF | |||
QBUL | 25.91 | -0.09 | -0.34% |
TrueShares Quarterly Bull Hedge ETF |
Ticker / NAME | Correlation To BCHMY | 1D Price Change % |
---|---|---|
BCHMY | 100% | N/A |
Process Industries category (451 stocks) | -1% Poorly correlated | +0.10% |
Chemicals: Major Diversified category (62 stocks) | -5% Poorly correlated | +0.01% |